<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "zidovudine inj VIAL">
<dose><value>1</value>
<value>2</value>
<value>120</value>
<value>20</value>
<value>1.5</value>
</dose>
<route><value>IV</value>
<value>IV </value>
</route>
<strength><value>10 mg/mL</value>
</strength>
<frequency><value>Q4H</value>
<value>Q6H</value>
<value>CONTINUOUS</value>
<value>Q12H</value>
<value>Q8H</value>
</frequency>
<instruction><value>Administer by continuous infusion.</value>
<value>Administer by continuous infusion for 1 hour (loading dose), then reduce to 1 mg/kg/hour until cord clamped.</value>
<value>Administer by continuous infusion until cord clamped.</value>
</instruction>
<volume><value>20 mL</value>
</volume>
<units><value>mg/kg</value>
<value>mg/m2</value>
<value>mg/m2/hour</value>
<value>mg/kg/dose</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Patients aged 12 years and older.</value>
<value>Patients aged 6 weeks to less than 12 years.</value>
<value>Patients aged 6 weeks to less than 12 years. </value>
<value>NEONATES: less than 30 weeks. Administer Q12H for 4 weeks, the Q8H for 2 weeks.</value>
<value>NEONATES: 30 - 34 weeks. Administer Q12H for 2 weeks, the Q8H for 4 weeks.</value>
<value>NEONATES: 35 weeks or more. Administer Q6H for 6 weeks.</value>
<value>Southern Alberta Clinic Perinatal Protocol</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3305</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antivirals, Antiretrovirals</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>